Additional file 3 of Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment

Table_3_Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.xlsx

Jianfeng Shu (12518655)
Jinni Jiang (16712829)
Guofang Zhao (7346297)

July 2023

BackgroundLung adenocarcinoma (LUAD) as a frequent type of lung cancer has a 5-year overall survival...

DataSheet1_Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.xlsx

Yiming Ma (450523)
Jun Yang (2084)
Tiantai Ji (13885323)
Fengyun Wen (11601955)

September 2022

Lung adenocarcinoma (LUAD) is the most prevalent subtype of non-small cell lung cancer (NSCLC) and i...

MOESM3 of Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma

Chundi Gao (6010835)
Jing Zhuang (49956)
Huayao Li (1611124)
Cun Liu (1606648)
Chao Zhou (471522)
Lijuan Liu (136685)
Changgang Sun (6010838)

November 2018

Additional file 3. The proteinâprotein interaction network of 118 methylation-driven genes and the...

Additional file 4 of Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment

Hao Zhou (136535)
Miaosen Zheng (10221335)
Muqi Shi (11308660)
Jinjie Wang (2048650)
Zhanghao Huang (11144217)
Haijian Zhang (11144220)
Youlang Zhou (8890943)
Jiahai Shi (229430)

August 2021

Additional file 4: Figure S3. Paired sample expression analyses of the seven key genes. (a) CLEC3B, ...

Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment

Hao Zhou
Miaosen Zheng
Muqi Shi
Jinjie Wang
Zhanghao Huang
Haijian Zhang
Youlang Zhou
Jiahai Shi

August 2021

Abstract Background Lung adenocarcinoma (LUAD) is a major subtype of lung cancer and closely associa...

MOESM3 of Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma

Qian Song (703098)
Jun Shang (1818454)
Zuyi Yang (6161654)
Lanlin Zhang (6423788)
Chufan Zhang (6423794)
Jianing Chen (491604)
Xianghua Wu (2212171)

March 2019

Additional file 3: Figure S1. The Kaplan–Meier survival analysis for the 30 immune related genes in ...

MOESM6 of Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma

Qian Song (703098)
Jun Shang (1818454)
Zuyi Yang (6161654)
Lanlin Zhang (6423788)
Chufan Zhang (6423794)
Jianing Chen (491604)
Xianghua Wu (2212171)

March 2019

Additional file 6: Figure S4. The KaplanâMeier survival analysis for the 30 immune related genes i...

MOESM5 of Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma

Qian Song (703098)
Jun Shang (1818454)
Zuyi Yang (6161654)
Lanlin Zhang (6423788)
Chufan Zhang (6423794)
Jianing Chen (491604)
Xianghua Wu (2212171)

March 2019

Additional file 5: Figure S3. The KaplanâMeier survival analysis for the 30 immune related genes i...

MOESM7 of Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma

Qian Song (703098)
Jun Shang (1818454)
Zuyi Yang (6161654)
Lanlin Zhang (6423788)
Chufan Zhang (6423794)
Jianing Chen (491604)
Xianghua Wu (2212171)

March 2019

Additional file 7: Figure S5. The KaplanâMeier survival analysis for the 30 immune related genes i...

MOESM4 of Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma

Chundi Gao (6010835)
Jing Zhuang (49956)
Huayao Li (1611124)
Cun Liu (1606648)
Chao Zhou (471522)
Lijuan Liu (136685)
Changgang Sun (6010838)

November 2018

Additional file 4. Pathway analysis of methylation-driven genes associated with LUAD (Pâ<â0.05)

Additional file 3: of RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue

Kobe Reynders (5526461)
Els Wauters (101718)
Matthieu Moisse (659185)
Herbert DecaluwĂŠ (5526488)
Paul De Leyn (5526455)
StĂŠphanie Peeters (5526485)
Maarten Lambrecht (5526458)
Kristiaan Nackaerts (3210705)
Christophe Dooms (2938749)
Wim Janssens (101722)
Johan Vansteenkiste (5526467)
Diether Lambrechts (101772)
Dirk De Ruysscher (810406)

July 2018

Figure S1. Differential methylated sites. Representation of the amount of methylated sites per gene ...

Additional file 3: of On Predicting lung cancer subtypes using ‘omic’ data from tumor and tumor-adjacent histologically-normal tissue

Arturo López Pineda (3403937)
Henry Ogoe (3403928)
Jeya Balasubramanian (3403925)
Claudia Rangel Escareño (3403934)
Shyam Visweswaran (487026)
James Herman (3403931)
Vanathi Gopalakrishnan (4640)

March 2016

Formatted TCGA dataset used in this study, along with sample IDs for classification task TAHNADC vs....

MOESM4 of Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma

Qian Song (703098)
Jun Shang (1818454)
Zuyi Yang (6161654)
Lanlin Zhang (6423788)
Chufan Zhang (6423794)
Jianing Chen (491604)
Xianghua Wu (2212171)

March 2019

Additional file 4: Figure S2. The KaplanâMeier survival analysis for the 30 immune related genes i...

Additional file 1 of Comprehensive analysis reveals the potential value of inflammatory response genes in the prognosis, immunity, and drug sensitivity of lung adenocarcinoma

Congkuan Song (9214229)
Shize Pan (11312142)
Donghang Li (9031859)
Bo Hao (1937338)
Zilong Lu (5434709)
Kai Lai (13817290)
Ning Li (45258)
Qing Geng (664188)

September 2022

Additional file 1. Figure S1. Acquisition of candidate genes and their expression patterns across th...

DataSheet2_Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.docx

Yiming Ma (450523)
Jun Yang (2084)
Tiantai Ji (13885323)
Fengyun Wen (11601955)

September 2022

Lung adenocarcinoma (LUAD) is the most prevalent subtype of non-small cell lung cancer (NSCLC) and i...

Table_3_Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.xlsx

Jianfeng Shu (12518655)
Jinni Jiang (16712829)
Guofang Zhao (7346297)

July 2023

BackgroundLung adenocarcinoma (LUAD) as a frequent type of lung cancer has a 5-year overall survival...

DataSheet1_Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.xlsx

Yiming Ma (450523)
Jun Yang (2084)
Tiantai Ji (13885323)
Fengyun Wen (11601955)

September 2022

Lung adenocarcinoma (LUAD) is the most prevalent subtype of non-small cell lung cancer (NSCLC) and i...

MOESM3 of Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma

Chundi Gao (6010835)
Jing Zhuang (49956)
Huayao Li (1611124)
Cun Liu (1606648)
Chao Zhou (471522)
Lijuan Liu (136685)
Changgang Sun (6010838)

November 2018

Additional file 3. The proteinâprotein interaction network of 118 methylation-driven genes and the...

Additional file 4 of Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment

Hao Zhou (136535)
Miaosen Zheng (10221335)
Muqi Shi (11308660)
Jinjie Wang (2048650)
Zhanghao Huang (11144217)
Haijian Zhang (11144220)
Youlang Zhou (8890943)
Jiahai Shi (229430)

August 2021

Additional file 4: Figure S3. Paired sample expression analyses of the seven key genes. (a) CLEC3B, ...

Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment

Hao Zhou
Miaosen Zheng
Muqi Shi
Jinjie Wang
Zhanghao Huang
Haijian Zhang
Youlang Zhou
Jiahai Shi

August 2021

Abstract Background Lung adenocarcinoma (LUAD) is a major subtype of lung cancer and closely associa...

MOESM3 of Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma

Qian Song (703098)
Jun Shang (1818454)
Zuyi Yang (6161654)
Lanlin Zhang (6423788)
Chufan Zhang (6423794)
Jianing Chen (491604)
Xianghua Wu (2212171)

March 2019

Additional file 3: Figure S1. The Kaplan–Meier survival analysis for the 30 immune related genes in ...

MOESM6 of Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma

Qian Song (703098)
Jun Shang (1818454)
Zuyi Yang (6161654)
Lanlin Zhang (6423788)
Chufan Zhang (6423794)
Jianing Chen (491604)
Xianghua Wu (2212171)

March 2019

Additional file 6: Figure S4. The KaplanâMeier survival analysis for the 30 immune related genes i...

MOESM5 of Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma

Qian Song (703098)
Jun Shang (1818454)
Zuyi Yang (6161654)
Lanlin Zhang (6423788)
Chufan Zhang (6423794)
Jianing Chen (491604)
Xianghua Wu (2212171)

March 2019

Additional file 5: Figure S3. The KaplanâMeier survival analysis for the 30 immune related genes i...

MOESM7 of Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma

Qian Song (703098)
Jun Shang (1818454)
Zuyi Yang (6161654)
Lanlin Zhang (6423788)
Chufan Zhang (6423794)
Jianing Chen (491604)
Xianghua Wu (2212171)

March 2019

Additional file 7: Figure S5. The KaplanâMeier survival analysis for the 30 immune related genes i...

MOESM4 of Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma

Chundi Gao (6010835)
Jing Zhuang (49956)
Huayao Li (1611124)
Cun Liu (1606648)
Chao Zhou (471522)
Lijuan Liu (136685)
Changgang Sun (6010838)

November 2018

Additional file 4. Pathway analysis of methylation-driven genes associated with LUAD (Pâ<â0.05)

Additional file 3: of RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue

Kobe Reynders (5526461)
Els Wauters (101718)
Matthieu Moisse (659185)
Herbert DecaluwĂŠ (5526488)
Paul De Leyn (5526455)
StĂŠphanie Peeters (5526485)
Maarten Lambrecht (5526458)
Kristiaan Nackaerts (3210705)
Christophe Dooms (2938749)
Wim Janssens (101722)
Johan Vansteenkiste (5526467)
Diether Lambrechts (101772)
Dirk De Ruysscher (810406)

July 2018

Figure S1. Differential methylated sites. Representation of the amount of methylated sites per gene ...

Additional file 3: of On Predicting lung cancer subtypes using ‘omic’ data from tumor and tumor-adjacent histologically-normal tissue

Arturo López Pineda (3403937)
Henry Ogoe (3403928)
Jeya Balasubramanian (3403925)
Claudia Rangel Escareño (3403934)
Shyam Visweswaran (487026)
James Herman (3403931)
Vanathi Gopalakrishnan (4640)

March 2016

Formatted TCGA dataset used in this study, along with sample IDs for classification task TAHNADC vs....

MOESM4 of Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma

Qian Song (703098)
Jun Shang (1818454)
Zuyi Yang (6161654)
Lanlin Zhang (6423788)
Chufan Zhang (6423794)
Jianing Chen (491604)
Xianghua Wu (2212171)

March 2019

Additional file 4: Figure S2. The KaplanâMeier survival analysis for the 30 immune related genes i...

Additional file 1 of Comprehensive analysis reveals the potential value of inflammatory response genes in the prognosis, immunity, and drug sensitivity of lung adenocarcinoma

Congkuan Song (9214229)
Shize Pan (11312142)
Donghang Li (9031859)
Bo Hao (1937338)
Zilong Lu (5434709)
Kai Lai (13817290)
Ning Li (45258)
Qing Geng (664188)

September 2022

Additional file 1. Figure S1. Acquisition of candidate genes and their expression patterns across th...

DataSheet2_Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.docx

Yiming Ma (450523)
Jun Yang (2084)
Tiantai Ji (13885323)
Fengyun Wen (11601955)

September 2022

Lung adenocarcinoma (LUAD) is the most prevalent subtype of non-small cell lung cancer (NSCLC) and i...

Table_3_Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.xlsx

Jianfeng Shu (12518655)
Jinni Jiang (16712829)
Guofang Zhao (7346297)

July 2023

BackgroundLung adenocarcinoma (LUAD) as a frequent type of lung cancer has a 5-year overall survival...

DataSheet1_Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.xlsx

Yiming Ma (450523)
Jun Yang (2084)
Tiantai Ji (13885323)
Fengyun Wen (11601955)

September 2022

Lung adenocarcinoma (LUAD) is the most prevalent subtype of non-small cell lung cancer (NSCLC) and i...

MOESM3 of Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma

Chundi Gao (6010835)
Jing Zhuang (49956)
Huayao Li (1611124)
Cun Liu (1606648)
Chao Zhou (471522)
Lijuan Liu (136685)
Changgang Sun (6010838)

November 2018

Additional file 3. The proteinâprotein interaction network of 118 methylation-driven genes and the...

Additional file 3 of Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment

Abstract

Extracted data

Additional file 3 of Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment

Abstract

Extracted data

Related items

Related items